Suven Pharmaceuticals

1,291.20
-17.90
(-1.37%)
Market Cap (₹ Cr.)
₹33,325
52 Week High
1,360.00
Book Value
₹81
52 Week Low
585.20
PE Ratio
136.96
PB Ratio
16.83
PE for Sector
41.08
PB for Sector
4.17
ROE
14.64 %
ROCE
41.69 %
Dividend Yield
0.00 %
EPS
₹9.45
Industry
Pharmaceuticals
Sector
Pharmaceuticals - Indian - Bulk Drugs & Formln
comparison:

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-19.72 %
Net Income Growth
-26.99 %
Cash Flow Change
-21.59 %
ROE
-38.23 %
ROCE
-30.48 %
EBITDA Margin (Avg.)
-6.12 %

Financial Results

Quarterly Financials
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Revenue
251
200
278
184
190
244
238
280
263
270
339
401
498
350
289
361
375
354
239
227
260
240
250
Expenses
129
95
147
99
108
126
140
138
166
149
179
206
206
184
172
201
187
174
127
144
171
139
135
EBITDA
122
105
131
85
82
118
98
142
97
120
160
195
292
166
117
160
188
180
112
83
89
101
114
Operating Profit %
49 %
52 %
46 %
45 %
41 %
47 %
41 %
50 %
36 %
43 %
40 %
48 %
43 %
46 %
38 %
42 %
49 %
49 %
43 %
32 %
30 %
37 %
43 %
Depreciation
6
6
6
6
7
7
8
9
8
9
9
11
10
11
11
11
11
11
11
11
16
12
12
Interest
2
3
4
7
7
3
3
2
2
2
1
1
2
1
0
1
5
1
1
2
2
2
2
Profit Before Tax
115
96
121
72
68
108
88
132
87
109
150
184
279
154
106
147
173
168
101
70
71
87
101
Tax
24
24
31
20
14
27
22
34
18
27
33
46
52
39
26
37
41
41
24
13
19
20
28
Net Profit
75
75
90
52
53
81
65
98
64
81
115
137
225
114
79
110
130
124
75
52
53
65
76
EPS in ₹
5.88
5.89
3.53
4.04
4.18
3.19
2.57
3.84
2.53
3.20
4.53
5.38
8.82
4.48
3.10
4.30
5.11
4.88
2.94
2.06
2.10
2.56
3.00

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
0
1,111
1,359
1,805
1,958
2,241
Fixed Assets
0
357
441
534
512
524
Current Assets
0
392
565
1,109
955
1,210
Capital Work in Progress
0
102
96
30
165
179
Investments
0
276
426
600
710
1,085
Other Assets
0
376
395
641
571
453
Total Liabilities
0
1,111
1,359
1,805
1,958
2,241
Current Liabilities
0
200
220
209
154
105
Non Current Liabilities
0
128
74
75
55
79
Total Equity
0
783
1,065
1,521
1,749
2,056
Reserve & Surplus
0
770
1,040
1,495
1,724
2,030
Share Capital
0
13
26
26
26
26

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
11
1
-5
23
13
-25
Investing Activities
-66
-367
-258
-90
-237
-382
Operating Activities
50
359
329
270
493
371
Financing Activities
26
9
-76
-157
-243
-14

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
50.10 %
50.10 %
50.10 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.01 %
10.14 %
9.54 %
9.80 %
10.70 %
DIIs
4.30 %
4.47 %
4.94 %
5.24 %
5.91 %
6.32 %
10.52 %
11.35 %
11.43 %
9.23 %
14.14 %
15.94 %
17.24 %
17.42 %
16.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
20.87 %
19.86 %
19.21 %
18.38 %
17.07 %
16.86 %
14.69 %
14.01 %
12.76 %
12.80 %
11.76 %
10.87 %
10.51 %
10.08 %
9.75 %

Dividend History

Peer Comparison Compare Peers on Screener

Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,797.70 4,33,931.70 38.70 49,887.20 12.06 9,648 27.34 51.02
1,534.80 1,21,755.80 26.38 26,520.70 14.17 4,155 12.95 47.09
2,603.05 1,04,826.50 49.54 10,615.60 19.57 1,942 28.89 52.27
1,223.00 1,01,936.60 19.09 28,905.40 12.36 5,578 -9.47 42.97
985.75 98,062.50 22.93 19,831.50 13.82 3,831 14.57 48.47
2,077.65 94,399.90 35.95 20,141.50 19.94 1,936 73.53 47.09
1,253.45 72,876.10 20.17 29,559.20 17.55 3,169 8.66 35.95
5,659.25 68,065.40 31.30 12,978.40 9.84 1,812 14.16 50.35
375.50 45,064.50 32.35 15,621.20 35.25 1,298 -84.31 68.22
1,556.50 43,670.00 - 12,653.10 6.58 -1,831 675.49 44.51

Corporate Action

Technical Indicators

RSI(14)
Neutral
58.25
ATR(14)
Volatile
45.20
STOCH(9,6)
Neutral
51.52
STOCH RSI(14)
Overbought
89.55
MACD(12,26)
Bearish
-0.76
ADX(14)
Weak Trend
21.84
UO(9)
Bearish
41.70
ROC(12)
Uptrend And Accelerating
8.68
WillR(14)
Neutral
-31.47